{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:07:05Z","timestamp":1784704025931,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Michael J Fox Foundation","award":["#008994"],"award-info":[{"award-number":["#008994"]}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CReATe- Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium\/NIH"},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-650-289"],"award-info":[{"award-number":["JPND2021-650-289"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LI 2654\/3-1"],"award-info":[{"award-number":["LI 2654\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LI 2654\/4-1 (Heisenberg)"],"award-info":[{"award-number":["LI 2654\/4-1 (Heisenberg)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto de Investigaci\u00f3n Biosanitaria ibs.GRANADA","award":["INTRAIBS-2020-06"],"award-info":[{"award-number":["INTRAIBS-2020-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The \u2018European Prospective Investigation into Cancer and Nutrition\u2019 cohort (EPIC) is a prospective study including\u2009~\u2009520,000 participants recruited across Europe (1991\u20132000) with in-depth baseline data on nutritional, lifestyle, medical, and anthropometric variables, and baseline blood samples. Here we introduce EPIC4ND, a case-cohort study within EPIC designed to identify biomarkers predicting a future onset of dementia, Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and amyotrophic lateral sclerosis (ALS). EPIC4ND comprises 6415 initially non-diseased participants (aged 35\u201380\u00a0years, mean age at baseline: 54\u2009\u00b1\u20099, 64% women) including 1899 incident cases with up to 30\u00a0years of follow-up and data on at least one omics domain available from pre-disease blood samples. EPIC4ND includes 4604 subcohort members (4441 non-cases and 163 incident cases) and 1811 additional incident cases ascertained from the broader EPIC cohort. Among the incident cases, there are 1190 dementia cases (818\n                    <jats:sc>AD<\/jats:sc>\n                    ), 610 PD cases, and 199 ALS cases. Additionally, 72 prevalent PD cases and 118 incident Parkinsonism cases are available for comparison. Molecular data generated encompass proteomics, genome-wide DNA methylation, and SNP genotyping with 4127 EPIC4ND participants (including 1635 incident cases) having data on all three domains. Smaller studies include data on metals, metabolites, and environmental chemicals, while ongoing efforts focus on ultrasensitive targeted biomarker measurements and small RNA sequencing. Genome-wide association studies and analyses of epidemiological risk factors validate the dataset by confirming many known risk factors. Leveraging these extensive pre-disease multi-layered\n                    <jats:italic>omics<\/jats:italic>\n                    data offers a unique opportunity to identify biomarker signatures predicting neurodegenerative diseases and to explore their interplay with epidemiological risk factors.\n                  <\/jats:p>","DOI":"10.1007\/s10654-026-01430-1","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:27:39Z","timestamp":1784701659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EPIC4ND\u2014European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-1307","authenticated-orcid":false,"given":"Christina M.","family":"Lill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Ohlei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Smith-Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Viallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Artaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Britten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Deecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerija","family":"Dobricic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Mokoroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafina","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Trupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jara","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Gr\u00f6ninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Colorado-Yohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Alonso-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Cabrera-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnni","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sture","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy Y. N.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefkos","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Katzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"Suppl 1","key":"1430_CR1","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.s6","volume":"26","author":"E Riboli","year":"1997","unstructured":"Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26(Suppl 1):S6\u201314. https:\/\/doi.org\/10.1093\/ije\/26.suppl_1.s6.","journal-title":"Int J Epidemiol."},{"issue":"6B","key":"1430_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113\u201324. https:\/\/doi.org\/10.1079\/PHN2002394.","journal-title":"Public Health Nutr"},{"issue":"6B","key":"1430_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1079\/PHN2002395","volume":"5","author":"N Slimani","year":"2002","unstructured":"Slimani N, Kaaks R, Ferrari P, et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr. 2002;5(6B):1125\u201345. https:\/\/doi.org\/10.1079\/PHN2002395.","journal-title":"Public Health Nutr"},{"issue":"3","key":"1430_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/sj.ejcn.1600694","volume":"53","author":"A Agudo","year":"1999","unstructured":"Agudo A, Amiano P, Barcos A, et al. Dietary intake of vegetables and fruits among adults in five regions of Spain. Eur J Clin Nutr. 1999;53(3):174\u201380. https:\/\/doi.org\/10.1038\/sj.ejcn.1600694.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"1430_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1079\/phn2000102","volume":"4","author":"SA Bingham","year":"2001","unstructured":"Bingham SA, Welch AA, McTaggart A, et al. Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr. 2001;4(3):847\u201358. https:\/\/doi.org\/10.1079\/phn2000102.","journal-title":"Public Health Nutr"},{"issue":"4","key":"1430_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000012787","volume":"43","author":"H Boeing","year":"1999","unstructured":"Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. Ann Nutr Metab. 1999;43(4):205\u201315. https:\/\/doi.org\/10.1159\/000012787.","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"1430_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/ije\/dyp217","volume":"39","author":"JWJ Beulens","year":"2010","unstructured":"Beulens JWJ, Monninkhof EM, Verschuren WMM, et al. Cohort profile: the EPIC-NL study. Int J Epidemiol. 2010;39(5):1170\u20138. https:\/\/doi.org\/10.1093\/ije\/dyp217.","journal-title":"Int J Epidemiol"},{"key":"1430_CR8","doi-asserted-by":"publisher","unstructured":"InterAct Consortium, Langenberg C, Sharp S, et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011;54(9):2272\u20132282. https:\/\/doi.org\/10.1007\/s00125-011-2182-9","DOI":"10.1007\/s00125-011-2182-9"},{"issue":"2","key":"1430_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10654-006-9096-8","volume":"22","author":"J Danesh","year":"2007","unstructured":"Danesh J, Saracci R, Berglund G, et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129\u201341. https:\/\/doi.org\/10.1007\/s10654-006-9096-8.","journal-title":"Eur J Epidemiol"},{"key":"1430_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328174","author":"EW Lopes","year":"2022","unstructured":"Lopes EW, Chan SSM, Song M, et al. Lifestyle factors for the prevention of inflammatory bowel disease. Gut. 2022. https:\/\/doi.org\/10.1136\/gutjnl-2022-328174.","journal-title":"Gut"},{"issue":"4","key":"1430_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ana.21653","volume":"65","author":"V Gallo","year":"2009","unstructured":"Gallo V, Bueno-De-Mesquita HB, Vermeulen R, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65(4):378\u201385. https:\/\/doi.org\/10.1002\/ana.21653.","journal-title":"Ann Neurol"},{"issue":"9","key":"1430_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","volume":"80","author":"V Gallo","year":"2013","unstructured":"Gallo V, Wark PA, Jenab M, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829\u201338. https:\/\/doi.org\/10.1212\/WNL.0b013e3182840689.","journal-title":"Neurology"},{"issue":"6","key":"1430_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000381857","volume":"15","author":"V Gallo","year":"2015","unstructured":"Gallo V, Brayne C, Forsgren L, et al. Parkinson\u2019s Disease Case Ascertainment in the EPIC cohort: The NeuroEPIC4PD study. Neurodegener Dis. 2015;15(6):331\u20138. https:\/\/doi.org\/10.1159\/000381857.","journal-title":"Neurodegener Dis"},{"issue":"3","key":"1430_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10654-016-0119-9","volume":"31","author":"V Gallo","year":"2016","unstructured":"Gallo V, Vanacore N, Bueno-de-Mesquita HB, et al. Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study. Eur J Epidemiol. 2016;31(3):255\u201366. https:\/\/doi.org\/10.1007\/s10654-016-0119-9.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1430_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ana.25932","volume":"89","author":"S Peters","year":"2021","unstructured":"Peters S, Broberg K, Gallo V, et al. Blood metal levels and amyotrophic lateral sclerosis risk: a prospective cohort. Ann Neurol. 2021;89(1):125\u201333. https:\/\/doi.org\/10.1002\/ana.25932.","journal-title":"Ann Neurol"},{"issue":"12","key":"1430_CR16","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/mds.29602","volume":"38","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Ray A, Broberg K, et al. Prediagnostic blood metal levels and the risk of Parkinson\u2019s disease: a large european prospective cohort. Mov Disord. 2023;38(12):2302\u20137. https:\/\/doi.org\/10.1002\/mds.29602.","journal-title":"Mov Disord"},{"issue":"8","key":"1430_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209201","volume":"102","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Lai Y, Konijnenberg H, et al. Association of coffee consumption and prediagnostic caffeine metabolites with incident parkinson disease in a population-based cohort. Neurology. 2024;102(8):e209201. https:\/\/doi.org\/10.1212\/WNL.0000000000209201.","journal-title":"Neurology"},{"issue":"11","key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10654-024-01183-9","volume":"39","author":"M Gr\u00f6ninger","year":"2024","unstructured":"Gr\u00f6ninger M, Sabin J, Kaaks R, et al. Associations of milk, dairy products, calcium and vitamin D intake with risk of developing Parkinson\u00b4s disease within the EPIC4ND cohort. Eur J Epidemiol. 2024;39(11):1251\u201365. https:\/\/doi.org\/10.1007\/s10654-024-01183-9.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"1430_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/mds.30054","volume":"40","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Lai Y, Darweesh SKL, et al. Gut microbial metabolites and future risk of Parkinson\u2019s disease: a metabolome-wide association study. Mov Disord. 2025;40(3):556\u201360. https:\/\/doi.org\/10.1002\/mds.30054.","journal-title":"Mov Disord"},{"issue":"2","key":"1430_CR20","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7(2):e105\u201325. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","journal-title":"The Lancet Public Health"},{"issue":"5","key":"1430_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","journal-title":"Lancet Neurol"},{"key":"1430_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR, Geiger JT, Chi\u00f2 A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408. https:\/\/doi.org\/10.1038\/ncomms12408.","journal-title":"Nat Commun"},{"issue":"4","key":"1430_CR23","doi-asserted-by":"publisher","first-page":"S545","DOI":"10.3233\/JAD-141482","volume":"42","author":"MS Rafii","year":"2014","unstructured":"Rafii MS. Preclinical Alzheimer\u2019s disease therapeutics. J Alzheimers Dis. 2014;42(4):S545\u20139. https:\/\/doi.org\/10.3233\/JAD-141482.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1430_CR24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","volume":"27","author":"S Palmqvist","year":"2021","unstructured":"Palmqvist S, Tideman P, Cullen N, et al. Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med. 2021;27(6):1034\u201342. https:\/\/doi.org\/10.1038\/s41591-021-01348-z.","journal-title":"Nat Med"},{"issue":"1","key":"1430_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23746-0","volume":"12","author":"NC Cullen","year":"2021","unstructured":"Cullen NC, Leuzy A, Janelidze S, et al. Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat Commun. 2021;12(1):3555. https:\/\/doi.org\/10.1038\/s41467-021-23746-0.","journal-title":"Nat Commun"},{"issue":"11","key":"1430_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2025.3217","volume":"82","author":"G Salvad\u00f3","year":"2025","unstructured":"Salvad\u00f3 G, Janelidze S, Bali D, et al. Plasma Phosphorylated Tau 217 to identify Preclinical Alzheimer disease. JAMA Neurol. 2025;82(11):1122\u201334. https:\/\/doi.org\/10.1001\/jamaneurol.2025.3217.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1430_CR27","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai H, Pang Y, Fu X, Ren Z, Jia L. Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts. Nat Commun. 2023;14(1):6747. https:\/\/doi.org\/10.1038\/s41467-023-42596-6.","journal-title":"Nat Commun"},{"issue":"1","key":"1430_CR28","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","volume":"16","author":"M Valletta","year":"2025","unstructured":"Valletta M, Vetrano DL, Gregorio C, et al. Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community. Nat Commun. 2025;16(1):10412. https:\/\/doi.org\/10.1038\/s41467-025-66728-2.","journal-title":"Nat Commun"},{"issue":"12","key":"1430_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00415-025-13498-y","volume":"272","author":"J Buonocore","year":"2025","unstructured":"Buonocore J, Fratto E, Arcuri F, et al. Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank. J Neurol. 2025;272(12):755. https:\/\/doi.org\/10.1007\/s00415-025-13498-y.","journal-title":"J Neurol"},{"issue":"6","key":"1430_CR30","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med. 2025;31(6):2027\u201335. https:\/\/doi.org\/10.1038\/s41591-025-03605-x.","journal-title":"Nat Med"},{"key":"1430_CR31","doi-asserted-by":"publisher","unstructured":"Shadyab AH, Zhang B, LaCroix AZ, et al. Plasma p-tau217 and incident mild cognitive impairment and dementia in older women: 25-year prospective study in The Women\u2019s Health Initiative Memory Study. medRxiv. Published online November 11, 2025. https:\/\/doi.org\/10.1101\/2025.10.30.25339146","DOI":"10.1101\/2025.10.30.25339146"},{"issue":"6","key":"1430_CR32","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A, Hatano T, Matsumoto G, et al. Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med. 2023;29(6):1448\u201355. https:\/\/doi.org\/10.1038\/s41591-023-02358-9.","journal-title":"Nat Med"},{"issue":"1","key":"1430_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","volume":"81","author":"S Yan","year":"2024","unstructured":"Yan S, Jiang C, Janzen A, et al. Neuronally derived extracellular vesicle \u03b1-Synuclein as a serum biomarker for individuals at risk of developing Parkinson Disease. JAMA Neurol. 2024;81(1):59\u201368. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4398.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1430_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.14802\/jmd.24075","volume":"17","author":"T Hatano","year":"2024","unstructured":"Hatano T, Okuzumi A, Matsumoto G, Tsunemi T, Hattori N. \u03b1-Synuclein: a promising biomarker for Parkinson\u2019s disease and related disorders. J Mov Disord. 2024;17(2):127\u201337. https:\/\/doi.org\/10.14802\/jmd.24075.","journal-title":"J Mov Disord"},{"issue":"10","key":"1430_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70382","volume":"32","author":"K Obara","year":"2025","unstructured":"Obara K, Ito D, Nilsson C, et al. Diagnostic and prognostic value of blood and cerebrospinal fluid biomarkers in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Eur J Neurol. 2025;32(10):e70382. https:\/\/doi.org\/10.1111\/ene.70382.","journal-title":"Eur J Neurol"},{"issue":"15","key":"1430_CR36","doi-asserted-by":"publisher","first-page":"e1466","DOI":"10.1212\/WNL.0000000000012632","volume":"97","author":"K Bjornevik","year":"2021","unstructured":"Bjornevik K, O\u2019Reilly EJ, Molsberry S, et al. Prediagnostic neurofilament light chain levels in amyotrophic lateral sclerosis. Neurology. 2021;97(15):e1466\u201374. https:\/\/doi.org\/10.1212\/WNL.0000000000012632.","journal-title":"Neurology"},{"issue":"5","key":"1430_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker KA, Chen J, Zhang J, et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat Aging. 2021;1(5):473\u201389. https:\/\/doi.org\/10.1038\/s43587-021-00064-0.","journal-title":"Nat Aging"},{"key":"1430_CR38","doi-asserted-by":"publisher","unstructured":"Walker KA, Chen J, Shi L, et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci Transl Med. 2023;15(705). https:\/\/doi.org\/10.1126\/scitranslmed.adf5681","DOI":"10.1126\/scitranslmed.adf5681"},{"issue":"10","key":"1430_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","volume":"4","author":"EA Frick","year":"2024","unstructured":"Frick EA, Emilsson V, Jonmundsson T, et al. Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nat Aging. 2024;4(10):1446\u201364. https:\/\/doi.org\/10.1038\/s43587-024-00693-1.","journal-title":"Nat Aging"},{"issue":"2","key":"1430_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","volume":"4","author":"Y Guo","year":"2024","unstructured":"Guo Y, You J, Zhang Y, et al. Plasma proteomic profiles predict future dementia in healthy adults. Nat Aging. 2024;4(2):247\u201360. https:\/\/doi.org\/10.1038\/s43587-023-00565-0.","journal-title":"Nat Aging"},{"issue":"4","key":"1430_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","volume":"5","author":"YH Gan","year":"2025","unstructured":"Gan YH, Ma LZ, Zhang Y, et al. Large-scale proteomic analyses of incident Parkinson\u2019s disease reveal new pathophysiological insights and potential biomarkers. Nat Aging. 2025;5(4):642\u201357. https:\/\/doi.org\/10.1038\/s43587-025-00818-0.","journal-title":"Nat Aging"},{"issue":"3","key":"1430_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/EDE.0000000000001469","volume":"33","author":"KM O\u2019Brien","year":"2022","unstructured":"O\u2019Brien KM, Lawrence KG, Keil AP. The case for case-cohort: an applied epidemiologist\u2019s guide to reframing case-cohort studies to improve usability and flexibility. Epidemiology. 2022;33(3):354\u201361. https:\/\/doi.org\/10.1097\/EDE.0000000000001469.","journal-title":"Epidemiology"},{"issue":"1-2","key":"1430_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000493209","volume":"52","author":"ME Andreu-Rein\u00f3n","year":"2019","unstructured":"Andreu-Rein\u00f3n ME, Gavrila D, Chirlaque MD, et al. Ascertainment of dementia cases in the Spanish European Prospective Investigation into Cancer and Nutrition-Murcia cohort. Neuroepidemiology. 2019;52(1\u20132):63\u201373. https:\/\/doi.org\/10.1159\/000493209.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"1430_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JAD-200774","volume":"78","author":"ME Andreu-Rein\u00f3n","year":"2020","unstructured":"Andreu-Rein\u00f3n ME, Huerta JM, Gavrila D, et al. Incidence of dementia and associated factors in the EPIC-Spain dementia cohort. J Alzheimers Dis. 2020;78(2):543\u201355. https:\/\/doi.org\/10.3233\/JAD-200774.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1430_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745\u201352. https:\/\/doi.org\/10.1136\/jnnp.51.6.745.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1430_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198736","volume":"14","author":"Z Harding","year":"2019","unstructured":"Harding Z, Wilkinson T, Stevenson A, et al. Identifying Parkinson\u2019s disease and parkinsonism cases using routinely collected healthcare data: A systematic review. PLoS ONE. 2019;14(1):e0198736. https:\/\/doi.org\/10.1371\/journal.pone.0198736.","journal-title":"PLoS ONE"},{"issue":"3","key":"1430_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10654-015-0090-x","volume":"31","author":"B Marin","year":"2016","unstructured":"Marin B, Logroscino G, Boum\u00e9diene F, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31(3):229\u201345. https:\/\/doi.org\/10.1007\/s10654-015-0090-x.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"1430_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/1877718X251330993","volume":"15","author":"TTH Nguyen","year":"2025","unstructured":"Nguyen TTH, Fournier A, Courtois \u00c9, et al. Use of \u03b2-adrenoreceptor drugs and Parkinson\u2019s disease incidence in women from the French E3N cohort study. J Parkinsons Dis. 2025;15(4):789\u2013804. https:\/\/doi.org\/10.1177\/1877718X251330993.","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"1430_CR49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00008469-199710000-00007","volume":"6","author":"F Clavel-Chapelon","year":"1997","unstructured":"Clavel-Chapelon F, van Liere MJ, Giubout C, et al. E3N, a French cohort study on cancer risk factors. Eur J Cancer Prev. 1997;6(5):473\u20138. https:\/\/doi.org\/10.1097\/00008469-199710000-00007.","journal-title":"Eur J Cancer Prev"},{"issue":"3","key":"1430_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-161305","volume":"61","author":"H L\u00f6vheim","year":"2018","unstructured":"L\u00f6vheim H, Olsson J, Weidung B, et al. Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer\u2019s Disease development. J Alzheimers Dis. 2018;61(3):939\u201345. https:\/\/doi.org\/10.3233\/JAD-161305.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1430_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41398-020-01074-z","volume":"10","author":"S Hong","year":"2020","unstructured":"Hong S, Prokopenko D, Dobricic V, et al. Genome-wide association study of Alzheimer\u2019s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. Transl Psychiatry. 2020;10(1):403. https:\/\/doi.org\/10.1038\/s41398-020-01074-z.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1430_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41398-022-02108-4","volume":"12","author":"V Dobricic","year":"2022","unstructured":"Dobricic V, Schilling M, Schulz J, et al. Differential microRNA expression analyses across two brain regions in Alzheimer\u2019s disease. Transl Psychiatry. 2022;12(1):352. https:\/\/doi.org\/10.1038\/s41398-022-02108-4.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1430_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biomet\/73.1.1","volume":"73","author":"RL Prentice","year":"1986","unstructured":"Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73(1):1\u201311. https:\/\/doi.org\/10.1093\/biomet\/73.1.1.","journal-title":"Biometrika"},{"issue":"4","key":"1430_CR54","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.2307\/2533444","volume":"50","author":"WE Barlow","year":"1994","unstructured":"Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994;50(4):1064\u201372.","journal-title":"Biometrics"},{"issue":"12","key":"1430_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/s0895-4356(99)00102-x","volume":"52","author":"WE Barlow","year":"1999","unstructured":"Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52(12):1165\u201372. https:\/\/doi.org\/10.1016\/s0895-4356(99)00102-x.","journal-title":"J Clin Epidemiol"},{"key":"1430_CR56","doi-asserted-by":"publisher","unstructured":"Onland-Moret NC, van der A DL, van der Schouw YT, et al. Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol. 2007;60(4):350\u2013355. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.06.022","DOI":"10.1016\/j.jclinepi.2006.06.022"},{"issue":"1","key":"1430_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12561-009-9001-6","volume":"1","author":"NE Breslow","year":"2009","unstructured":"Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. Improved Horvitz-Thompson estimation of model parameters from two-phase stratified samples: applications in epidemiology. Stat Biosci. 2009;1(1):32. https:\/\/doi.org\/10.1007\/s12561-009-9001-6.","journal-title":"Stat Biosci"},{"issue":"3","key":"1430_CR58","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/ije\/dyy230","volume":"48","author":"V Gallo","year":"2019","unstructured":"Gallo V, Vineis P, Cancellieri M, et al. Exploring causality of the association between smoking and Parkinson\u2019s disease. Int J Epidemiol. 2019;48(3):912\u201325. https:\/\/doi.org\/10.1093\/ije\/dyy230.","journal-title":"Int J Epidemiol"},{"issue":"10248","key":"1430_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet"},{"issue":"6","key":"1430_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893\u2013901. https:\/\/doi.org\/10.1002\/ana.23687.","journal-title":"Ann Neurol"},{"issue":"12","key":"1430_CR61","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1430_CR62","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138. https:\/\/doi.org\/10.1038\/ng.2802.","journal-title":"Nat Genet"},{"issue":"4","key":"1430_CR63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"issue":"12","key":"1430_CR64","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen W, van der Spek RAA, Bakker MK, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636\u201348. https:\/\/doi.org\/10.1038\/s41588-021-00973-1.","journal-title":"Nat Genet"},{"issue":"7726","key":"1430_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z.","journal-title":"Nature"},{"issue":"7982","key":"1430_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"issue":"7982","key":"1430_CR67","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023;622(7982):348\u201358. https:\/\/doi.org\/10.1038\/s41586-023-06563-x.","journal-title":"Nature"},{"key":"1430_CR68","doi-asserted-by":"publisher","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, et al. Correction to: Large-scale plasma proteomics comparisons through genetics and disease associations (Nature, (2023), 622, 7982, (348\u2013358), https:\/\/doi.org\/10.1038\/s41586-023-06563-x). Nature.Nature Research. 2024;630(8015):E3. 10.1038\/s41586\u2013024\u201307549-z","DOI":"10.1038\/s41586-023-06563-x"},{"issue":"1","key":"1430_CR69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12883-023-03361-w","volume":"23","author":"JB Lusk","year":"2023","unstructured":"Lusk JB, Choi S, Clark AG, et al. Dementia and Parkinson\u2019s disease diagnoses in electronic health records vs Medicare claims data: a study of 101,980 linked patients. BMC Neurol. 2023;23(1):325. https:\/\/doi.org\/10.1186\/s12883-023-03361-w.","journal-title":"BMC Neurol"},{"issue":"5","key":"1430_CR70","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","volume":"15","author":"MA Hern\u00e1n","year":"2004","unstructured":"Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5):615\u201325. https:\/\/doi.org\/10.1097\/01.ede.0000135174.63482.43.","journal-title":"Epidemiology"},{"issue":"2","key":"1430_CR71","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/aje\/kwp107","volume":"170","author":"B Lau","year":"2009","unstructured":"Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244\u201356. https:\/\/doi.org\/10.1093\/aje\/kwp107.","journal-title":"Am J Epidemiol"},{"issue":"24","key":"1430_CR72","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1002\/sim.2098","volume":"23","author":"ACM Thi\u00e9baut","year":"2004","unstructured":"Thi\u00e9baut ACM, B\u00e9nichou J. Choice of time-scale in Cox\u2019s model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004;23(24):3803\u201320. https:\/\/doi.org\/10.1002\/sim.2098.","journal-title":"Stat Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01430-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01430-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:27:41Z","timestamp":1784701661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-026-01430-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":72,"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s10654-026-01430-1","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Z. has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Enigma, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. None of the other authors reports any relevant conflict of interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the International Agency for Research on Cancer (IARC) and by the ethical review boards of participating study centers.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}